Skip to content

Scholar Rock SRRK Total Liabilities

Total Liabilities at other companies

Biogen logo
BiogenBIIB
$305.1M-97.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$3.64B+44.4%
Roivant Sciences logo
Roivant SciencesROIV
$416.28M+66.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's total liabilities?
Scholar Rock (SRRK) reported total liabilities of $259.24M in Q1 2026.
How has Scholar Rock's total liabilities changed year-over-year?
Scholar Rock's total liabilities increased by 172.3% year-over-year, from $95.22M to $259.24M.
What is the long-term trend for Scholar Rock's total liabilities?
Over 5 years (2020 to 2025), Scholar Rock's total liabilities has grown at a 4.5% compound annual growth rate (CAGR), from $127.54M to $158.78M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.